William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!

Why Is Sweetgreen (SG) Stock Up 25% Today?

Sweetgreen stock is rising higher on Friday as SG investors learn of mixed earnings results and a strong revenue guidance for 2024.

Why Is Iovance Bio (IOVA) Stock Up 18% Today?

Iovance Biotherapeutics stock is gaining as IOVA investors react to strong Q2 earnings beats and positive guidance for 2024 and 2025.

ELF Stock Is Down 15% Today? What’s Going on With e.l.f. Beauty?

E.l.f. Beauty stock is falling on Friday after the company disappointed ELF investors with weak 2025 guidance despite beating Q1 estimates.

Why Is Marin Software (MRIN) Stock Up 32% Today?

Marin Software stock is up on Friday with heavy trading of MRIN shares alongside an update to its advertising platform.

Why Is Doximity (DOCS) Stock Up 30% Today?

Doximity stock is up on Friday as DOCS investors react to earnings and revenue beats alongside strong fiscal 2025 guidance.

FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock?

FSD Pharma stock is up on Friday as HUGE investors react to an update on its investment in Celly Nutrition and a new product launch.

Why Is MGO Global (MGOL) Stock Up 54% Today?

MGO Global stock is up on Friday after the company issued shares to its leadership team and saw heavy trading of MGOL today.

Why Is American Vanguard (AVD) Stock Down 28% Today?

American Vanguard stock is down on Friday after AVD investors learned of the company missing Q2 estimates and cutting revenue guidance.

Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?

AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.